Why the study?
Does renin-angiotensin system blockade with valsartan alone or combined with aliskiren restore the circadian arterial pressure rhythm in mRen2.Lewis hypertensive rats?
Does renin-angiotensin system blockade with valsartan alone or combined with aliskiren restore the circadian arterial pressure rhythm in mRen2.Lewis hypertensive rats?
Blockade of the renin-angiotensin system with valsartan and aliskiren normalizes the altered circadian arterial pressure rhythm in a renin-dependent hypertension rat model, highlighting the role of Ang II in circadian desynchronization.
Answers are grounded in this paper and cite their sources.
Extends preclinical evidence for RAS blockade restoring circadian BP rhythm in renin-dependent rats; leaves open any clinical translation or practice change.
BACKGROUND: Alterations in the circadian arterial pressure rhythm predict cardiovascular mortality. We examined the circadian arterial pressure rhythm and the effect of renin-angiotensin system blockade in congenic mRen2.Lewis hypertensive rats, a renin-dependent model of hypertension derived from the backcross of transgenic hypertensive [mRen-2]27 rats with Lewis normotensive ones. METHODS: Twenty-nine mRen2.Lewis hypertensive rats were randomly assigned to drink tap water (vehicle; n = 9), valsartan (30 mg/kg/day; n = 10), or valsartan (30 mg/kg/day) combined with aliskiren given subcutaneously (50 mg/kg/day; n = 10) for 2 weeks. Arterial pressure, heart rate, and locomotive activity were recorded with chronically implanted radiotelemetry probes. The awake/asleep ratio was calculated as [awake mean arterial pressure (MAP) mean - asleep MAP mean)] / (awake MAP mean) x 100. Plasma renin activity (PRA) and concentration (PRC), and plasma and kidney angiotensin II (Ang II) were measured by radioimmunoassay (RIAs). RESULTS: Untreated hypertensive rats showed an inverse arterial pressure rhythm, higher at day and lower at night, accompanied by normal rhythms of heart rate and locomotive activity. Treatment with valsartan or aliskiren and valsartan normalized the elevated arterial pressure and the arterial pressure rhythm, with the combination therapy being more effective in reducing MAP and in restoring the awake/asleep ratio. While PRA and PRC increased with the treatments, the addition of aliskiren to valsartan partially reversed the increases in plasma Ang II levels. Valsartan and the aliskiren and valsartan combination markedly reduced the renal cortical content of Ang II. CONCLUSION: The altered circadian arterial pressure rhythm in this renin-dependent hypertension model uncovers a significant role of Ang II in the desynchronization of the circadian rhythm of arterial pressure, heart rate, and locomotive activity.
No takes yet. Share an insight, caveat, or question.
Moniwa et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: